Single-photon emission tomography imaging of monoamine transporters in impulsive violent behaviour

European Journal of Nuclear Medicine

Volumn 24, Issue 10, 1997, Pages 1253-1260

  Tiihonen, Jari ^a   Kuikka, Jyrki T ^b   Bergström, Kim A ^b   Karhu, Jari ^b   Viinamäki, Heimo ^b   Lehtonen, Johannes ^b   Hallikainen, Tero ^a   Yang, Jiwei ^b   Hakola, Panu ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Alcoholics; Impulsiveness; Monoamine transporters; Receptors; Single photon emission tomography

Indexed keywords

3BETA (4 IODOPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; CARRIER PROTEIN; DOPAMINE; DOPAMINE TRANSPORTER; IODINE 123; MONOAMINE; SEROTONIN; TRACER;

ADULT; AMINE TRANSPORT; ARTICLE; BRAIN; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMPULSIVENESS; MALE; MESENCEPHALON; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; VIOLENCE;

ADULT; ALCOHOLISM; BRAIN; CARRIER PROTEINS; CASE-CONTROL STUDIES; COCAINE; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; HUMANS; IMPULSIVE BEHAVIOR; IODINE RADIOISOTOPES; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; REPRODUCIBILITY OF RESULTS; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VIOLENCE;

EID: 0030717696     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050149     Document Type: Article

References (55)

1. Hammett M, Powell KE, O'Carroll PW, Clanton ST. Homicide surveillance - United States, 1979-1988. MMWR CDC Surveill Summ 1992; 41: 1-33.
2. Brown GL, Goodwill FK, Ballenger JC, Goyer PF, Major LF. Aggression in humans correlates with cerebrospinal fluid amine metabolites. Psychiatry Res 1979; 1: 131-139.
3. Linnoila M, Virkkunen M, Scheinin M, Nuutila A, Rimon R, Goodwill R. Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from nonimpulsive violent behaviour. Life Sci 1983; 33: 2609-2614.
4. Virkkunen M, Nuutila A, Goodwin FK, Linnoila M. Cerebrospinal fluid monoamine metabolites in male arsonists. Arch Gen Psychiatry 1987; 44: 241-247.
5. Coccaro EF, Siever LJ, Klar HM, et al. Serotonergic studies in patients with affective and personality disorders. Correlates with suicidal and impulsive aggressive behaviour. Arch Gen Psychiatry 1989; 46: 587-599.
6. Roy A, Virkkunen M, Linnoila M. Serotonin in suicide, violence, and alcoholism. In: Coccaro E, Murphy D, eds. Serotonin in major psychiatric disorders. Washington, DC: American Psychiatric Association; 1991: 187-208.
7. Cloninger CR, Sigvardsson S, von Knorring A-L, Bohman M. The Swedish studies of the adopted children of alcoholics: a reply to Littrell. J Stud Alcohol 1988; 49: 500-509.
8. Virkkunen M, DeJong J, Bartko J, Goodwin FK, Linnoila M. Relationship of psychobiological variables to recidivism in violent offenders and impulsive fire setters. Arch Gen Psychiatry 1989; 46: 600-603.
9. Virkkunen M, Rawlings R, Tokola R, et al. CSF biochemistries, glucose metabolism, and diurnal activity rhythms in alcoholic, violent offenders, fire setters, and healthy volunteers. Arch Gen Psychiatry 1994; 251: 20-27.
10. Uhl GR. Neurotransmitter transporter (plus): a promising new gene family. Trends Neurosci 1992; 15: 265-268.
11. 11C-nomifensine and positron emission tomography. Acta Neurol Scand 1987; 76: 283-287.
12. 18F] GBR 13119 to the brain dopamine uptake system. Life Sci 1988; 42: 1347-1353.
13. Fowler JS, Volkow ND, Wolf A, et al. Mapping cocaine binding sites in human and baboon in vivo. Synapse 1989; 4: 371-377.
14. 125I]RTI-55: in vitro binding and autoradiographic characterization. J Neurochem 1994; 62: 549-556.
15. 11C-raclopride. Psychopharmacology 1987; 92: 278-284.
16. Wagner HN Jr, Burns HD, Dannals RF, et al. Imaging dopamine receptors in the human brain by positron tomography. Science 1983; 221: 1264-1266.
17. Kung HF, Alavi A, Chang W, et al. In vivo SPECT imaging of CNS D-2 dopamine receptors: initial studies with iodine-123-IBZM in humans. J Nucl Med 1990; 31: 573-579.
18. 18F] altanserine. J Nucl Med 1990; 31: 1584.
19. Petit-Taboué MC, Landeau B, Osmong A, Tillet I, Barré L, Baron J-C. Estimation of neocortical serotonin-2 receptor binding potential by single-dose fluorine-18 setoperone kinetic PET data analysis. J Nucl Med 1996; 37: 95-104.
20. 3H]paroxetine binding to serotonin uptake sites in human brain tissue. Brain Res 1989; 486: 261-268.
21. 123I]β-CIT. Eur J Pharmacol 1991; 200: 369-370.
22. Shaya EK, Scheffel U, Dannals RF, et al. In vivo imaging of dopamine reuptake sites in the primate brain using single photon emission computed tomography (SPECT) and iodine-123 labeled RTI-55. Synapse 1992; 410: 169-172.
23. 123I]-2β-carbomethoxy-3β-(4-iodophenyl)tropane: high-affinity SPECT radiotracer of monoamine reuptake sites in brain. Eur J Med Chem 1991; 34: 3144-3146.
24. Kuikka JT, Tiihonen J, Bergström KA, et al. Imaging of serotonin and dopamine transporters in the living human brain. Eur J Nucl Med 1995; 22: 346-350.
25. 11C]β-CIT binding to monoamine transporters in the monkey and human brain. Synapse 1994; 16: 93-103.
26. 123I]β-CIT. Binding kinetics in the human brain. J Neural Transm 1993; 94: 137-146.
27. Innis R, Seibyl J, Wallace E, et al. SPECT imaging demonstrates loss of striatal dopamine transporters in Parkinson's disease. Proc Natl Acad Sci USA 1993; 90: 11965-11969.
28. Kuikka JT, Bergström KA, Ahonen A, Länsimies E. The dosimetry of iodine-123 labelled 2β-carbomethoxy-3β-(4-iodophenyl)tropane. Eur J Nucl Med 1994; 21: 53-56.
29. 123I]β-CIT: pharmacological characterization of brain uptake in nonhuman primates. Synapse 1993; 13: 295-309.
30. Cloninger CR. Neurogenetic adaptive mechanisms in alcoholism. Science 1987; 216: 410-416.
31. 123I]β-CIT, a tracer for dopamine and serotonin reuptake sites, preparation and preliminary SPET studies in humans. J Nucl Biol Med 1994; 38: S128-S131.
32. Kuikka JT, Tenhunen-Eskelinen M, Jurvelin J, Kiiliäinen H. Physical performance of the Siemens MultiSPECT 3 gamma camera. Nucl Med Commun 1993; 14: 490-497.
33. Nicolás JM, Catafau AM, Estruch R, et al. Regional cerebral blood flow-SPECT in chronic alcoholism: relation to neuropsychological testing. J Nucl Med 1993; 34: 1452-1459.
34. Tiihonen J, Kuikka J, Bergström K, et al. Altered striatal dopamine re-uptake site densities in habitually violent and non-violent alcoholics. Nature Med 1995; 1: 654-657.
35. Tiihonen J, Eronen M, Hakola P. Criminality associated with mental disorders and intellectual deficiency. Arch Gen Psychiatry 1993; 50: 917-918.
36. Tiihonen J, Hakola P. Psychiatric disorders and homicide recidivism. Am J Psychiatry 1994; 151: 436-438.
37. Åsberg M, Nordström P, Träskman-Bendz L. Cerebrospinal fluid studies in suicide. In: Mann JJ, Stanley M, eds. Psychobiology of suicidal behaviour. New York: Ann N Y Acad Sci; 1986: 243-255.
38. Irwin M, Schuckit M, Smith TL. Clinical importance of age at onset in type 1 and type 2 primary alcoholics. Arch Gen Psychiatry 1990; 47: 320-324.
39. Hitri A, Casanova MF, Kleinman JE, Wyatt RJ. Fewer dopamine transporter receptors in the prefrontal cortex of cocaine users. Am J Psychiatry 1994; 151: 1074-1076.
40. 3H]paroxetine binding to cerebral cortical membranes of the rat. Neuropharmacology 1987; 26: 1087-1092.
41. Callaway JC, Airaksinen MM, McKenna DJ, Brito GS, Grob CS. Platelet serotonin uptake sites increased in drinkers of ayahuasca. Psychopharmacology 1995; 116: 385-387.
42. Heinz A, Ragan P, Jones DW, et al. Reduced binding potential of serotonin transporters in the raphe of alcohol-dependent patients [abstract]. J Nucl Med 1997; 38: 48P.
43. 3H]imipramine binding in the human brain postmortem: effects of age and alcohol. J Neurochem 1988; 51: 528-534.
44. 123I]β-CIT determined with a gradient HPLC method. Nucl Med Biol 1995; 22: 971-976.
45. 123I]β-CIT binding to dopamine and serotonin transporters. Eur J Nucl Med 1996; 23: 431-436.
46. Pirker W, Asenbaum S, Kasper S, et al. β-CIT SPECT demonstrates blockade of 5HT-uptuke sites by citalopram in the human brain in vivo. J Neural Transm 1995; 100: 247-256.
47. Fuster JM. Prefrontal cortex. Anatomy, physiology, and neurophysiology of the frontal lobe. 2nd edn. New York: Raven Press, 1989.
48. Damasio H, Grabowski T, Frank R, Galaburda AM, Damasio AR. The return of Phineas Gage: clues about the brain from the skull of a famous patient. Science 1994; 264: 1102-1105.
49. Cloninger CR. The psychobiological regulation of social cooperation. Nature Med 1995; 1: 621-624.
50. O'Neil M, Page N, Adkins WN, Eichelman B. Tryptonphantrazodone treatment of aggressive behaviour. Lancet 1986; II: 859-860.
51. Volavka J, Crowner M, Brizer D, Convit A, Van-Praag H, Suckow RF. Tryptophan treatment of aggressive psychiatric inpatients. Biol Psychiatry 1990; 28; 728-732.
52. Markovitz PJ, Calahrese JR, Schulz SC, Meltzer HY. Fluoxetine in the treatment of borderline and schizotypal personality disorders. Am J Psychiatry 1991; 148: 1064-1067.
53. Tiihonen J, Hakola P, Paanila J, Turtiainen M. Eltoprazine for aggression in schizophrenia and mental retardation. Lancet 1993; 341: 307.
54. Kaplan JR, Botchin MB, Shively CA, Manuck SB, Muldoon M, Mann JJ. Inherent and environmental factors influencing central serotonergic activity and behaviour in monkeys. Neuropsychopharmacology 1994; 10(3S): 389.
55. Higley JD, Suomi SJ, Linnoila M. Genetic and environmental influences producing long-term, trait-like interindividual differences in the concentrations of CSF 5-hydroxyindoleacetic acid in nonhuman primates. Neuropsychopharmacology 1994; 10(3S): 388.